PAM
LXEO icon

Panagora Asset Management’s Lexeo Therapeutics LXEO Stock Holding History

Panagora Asset Management’s Portfolio LXEO Stock Details LXEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$197K Hold
34,297
– – ﹤0.01% 1104
2025
Q4 		$341K Hold
34,297
– – ﹤0.01% 966
2025
Q3 		$228K Sell
34,297
-444
-1% -$2.15K ﹤0.01% 1053
2025
Q2 		$140K Hold
34,741
– – ﹤0.01% 1080
2025
Q1 		$121K Buy
+34,741
New +$154K ﹤0.01% 1071

Other funds holding LXEO

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Panagora Asset Management's LXEO Position: Q1 2026 in Review

Panagora Asset Management held its Lexeo Therapeutics (LXEO) position steady in Q1 2026 at 34,297 shares worth $197K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Panagora Asset Management first reported a position in LXEO in Q1 2025 and has held it in 5 quarters since. The position peaked at $341K in Q4 2025. 139 funds tracked by Wall St. Rank hold LXEO as of Q1 2026.

  • Panagora Asset Management held 34,297 shares of Lexeo Therapeutics worth $197K as of Q1 2026.
  • Panagora Asset Management left its Lexeo Therapeutics share count unchanged in Q1 2026.
  • Lexeo Therapeutics made up ﹤0.01% of Panagora Asset Management's portfolio in Q1 2026, its #1104 holding.
  • Panagora Asset Management first reported a position in Lexeo Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Panagora Asset Management's Lexeo Therapeutics position peaked at $341K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Lexeo Therapeutics as of Q1 2026.

Based on Panagora Asset Management's 13F filing for Q1 2026, filed 14 May 2026.